#United States #New York #Securities Fraud #Rosen Law Firm #ModivCare Inc

Investors Encouraged to Participate in ModivCare Class Action

The Rosen Law Firm, a prominent law firm focused on investor rights, has announced significant developments for those who purchased shares of ModivCare Inc. (NASDAQ: MODV) between November 3, 2022, and September 15, 2024. Investors are urged to consider joining an actively filed class action lawsuit with a crucial deadline approaching on March 31, 2025.

Why Join the Class Action?

Individuals who purchased ModivCare securities during the specified period may be eligible for compensation under a contingency fee structure. This means that potential class members can seek damages without incurring any out-of-pocket costs for legal fees. It’s an opportunity for affected investors to recover losses resulting from alleged securities fraud without bearing financial burdens upfront.

Next Steps for Interested Investors

Those interested in joining the ModivCare class action are encouraged to visit this link for further information. Alternatively, investors can reach out directly to Phillip Kim, Esq., at (866) 767-3653, or email pkim@rosenlegal.com to learn how to get involved.

It’s important to note that to serve as a lead plaintiff—representing the interests of the class in litigation—interested parties must submit their motion to the Court before the March 31 deadline. A lead plaintiff plays a crucial role in directing the case and working with legal counsel on behalf of all class members.

The Legal Background

The class action lawsuit centers on allegations that during the Class Period, ModivCare's executives made materially false and misleading statements, failing to disclose significant adverse facts regarding the company's operations. Specifically, it is claimed that contracts within ModivCare's non-emergency medical transportation (NEMT) segment had a detrimental effect on their free cash flow.

The suit asserts that this misrepresentation resulted in severe implications for ModivCare's financial standings, including:

• - Deterioration of Free Cash Flow: The lawsuits contend that various contractual obligations negatively impacted the company's liquidity.
• - Misleading Positive Statements: Investors were misled by optimistic projections regarding the company's business state, devoid of a legitimate foundation.
• - Damages Suffered by Investors: When accurate information became public, many investors reportedly suffered substantial financial losses in their ModivCare holdings.

The Importance of Experienced Legal Counsel

Choosing qualified legal counsel is vital in such situations. The Rosen Law Firm emphasizes its extensive experience in securities litigation, inviting investors to select representatives with proven success in leading roles during class actions. Many law firms serve merely as intermediaries, lacking the capabilities to litigate these cases effectively.

Established as a frontrunner in securities litigation, the Rosen Law Firm has successfully recovered hundreds of millions in settlements, distinguishing itself with the largest securities class action against a Chinese company at that time. Laurence Rosen, the firm’s founding partner, has received accolades such as being recognized by Law360 as a Titan of the Plaintiffs’ Bar. The law firm continues its emphasis on securing justice for investors globally.

Conclusion

As the March 31, 2025, deadline approaches, affected ModivCare investors should consider their options promptly. Joining a class action lawsuit can provide a platform for those impacted by alleged securities fraud to reclaim their losses. Interested individuals should act swiftly to secure their potential positions within this critical litigation.

To stay informed about developments related to the case, follow the Rosen Law Firm’s updates on social media through LinkedIn, Twitter, and Facebook. Investor rights remain a significant aspect of maintaining corporate accountability, and participation in such cases highlights the importance of protecting those interests.